Morgan Stanley
KRMD icon

Morgan Stanley’s KORU Medical Systems KRMD Stock Holding History

Morgan Stanley’s Portfolio KRMD Stock Details KRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
322,959
-46,067
-12% -$189K ﹤0.01% 5075
2026
Q1 		$1.59M Sell
369,026
-58,000
-14% -$288K ﹤0.01% 4898
2025
Q4 		$2.48M Buy
427,026
+92,809
+28% +$444K ﹤0.01% 4660
2025
Q3 		$1.28M Buy
334,217
+34,397
+11% +$132K ﹤0.01% 5046
2025
Q2 		$1.07M Buy
299,820
+106,612
+55% +$303K ﹤0.01% 5055
2025
Q1 		$491K Buy
193,208
+106,900
+124% +$397K ﹤0.01% 5330
2024
Q4 		$332K Sell
86,308
-4,381
-5% -$14.2K ﹤0.01% 5585
2024
Q3 		$248K Sell
90,689
-77,521
-46% -$191K ﹤0.01% 5673
2024
Q2 		$446K Buy
168,210
+21,862
+15% +$50K ﹤0.01% 5340
2024
Q1 		$345K Buy
146,348
+70,756
+94% +$152K ﹤0.01% 5486
2023
Q4 		$186K Buy
75,592
+31,875
+73% +$75.9K ﹤0.01% 5732
2023
Q3 		$118K Buy
43,717
+7,144
+20% +$19.6K ﹤0.01% 5804
2023
Q2 		$126K Sell
36,573
-13,399
-27% -$52.6K ﹤0.01% 5838
2023
Q1 		$211K Buy
49,972
+22,176
+80% +$87.2K ﹤0.01% 5686
2022
Q4 		$99.2K Buy
27,796
+10,642
+62% +$29.3K ﹤0.01% 5978
2022
Q3 		$38K Buy
17,154
+6,958
+68% +$17.2K ﹤0.01% 6531
2022
Q2 		$26K Buy
10,196
+4,909
+93% +$11.9K ﹤0.01% 6885
2022
Q1 		$15K Sell
5,287
-169,277
-97% -$507K ﹤0.01% 7263
2021
Q4 		$524K Sell
174,564
-58,487
-25% -$179K ﹤0.01% 5515
2021
Q3 		$664K Sell
233,051
-161,135
-41% -$533K ﹤0.01% 5322
2021
Q2 		$1.82M Sell
394,186
-101,680
-21% -$399K ﹤0.01% 4700
2021
Q1 		$1.75M Buy
495,866
+415,957
+521% +$1.8M ﹤0.01% 4356
2020
Q4 		$482K Buy
79,909
+55,282
+224% +$309K ﹤0.01% 5102
2020
Q3 		$177K Buy
24,627
+1,543
+7% +$13.7K ﹤0.01% 5177
2020
Q2 		$208K Buy
23,084
+9,912
+75% +$100K ﹤0.01% 5058
2020
Q1 		$99K Buy
13,172
+6,212
+89% +$41.8K ﹤0.01% 5191
2019
Q4 		$45K Buy
+6,960
New +$33.9K ﹤0.01% 5889

Other funds holding KRMD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
LCM
Lionhunter Capital Management New York $222M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Morgan Stanley's KRMD Position: Q2 2026 in Review

Morgan Stanley reduced its KORU Medical Systems (KRMD) stake by 12% in Q2 2026, selling an estimated $189K and leaving 322,959 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #5075.

Morgan Stanley first reported a position in KRMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.48M in Q4 2025. 85 funds tracked by Wall St. Rank hold KRMD as of Q2 2026.

  • Morgan Stanley held 322,959 shares of KORU Medical Systems worth $1.36M as of Q2 2026.
  • Morgan Stanley sold 46,067 KORU Medical Systems shares in Q2 2026, an estimated $189K.
  • KORU Medical Systems made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5075 holding.
  • Morgan Stanley first reported a position in KORU Medical Systems in Q4 2019 and has held it in 27 quarters since.
  • Morgan Stanley's KORU Medical Systems position peaked at $2.48M in Q4 2025.
  • 85 funds tracked by Wall St. Rank held KORU Medical Systems as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.